Page last updated: 2024-09-03

ro 8-0576 and alpha-synuclein

ro 8-0576 has been researched along with alpha-synuclein in 1 studies

Compound Research Comparison

Studies (ro 8-0576)	Trials (ro 8-0576)	Recent Studies (post-2010) (ro 8-0576)	Studies (alpha-synuclein)	Trials (alpha-synuclein)	Recent Studies (post-2010) (alpha-synuclein)
214	63	67	10,821	29	8,011

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, NH; Heng, Y; Huang, JY; Mou, Z; Yuan, YH; Zhang, QS	1

Other Studies

1 other study(ies) available for ro 8-0576 and alpha-synuclein

Article	Year
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta pharmacologica Sinica, 2017, Volume: 38, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Antiparkinson Agents; Astrocytes; Behavior, Animal; Benserazide; Benzothiazoles; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Drug Combinations; Levodopa; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Parkinsonian Disorders; Pramipexole; Selegiline	2017

Article

Year

Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease.

Acta pharmacologica Sinica, 2017, Volume: 38, Issue:10

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Antiparkinson Agents; Astrocytes; Behavior, Animal; Benserazide; Benzothiazoles; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Drug Combinations; Levodopa; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Parkinsonian Disorders; Pramipexole; Selegiline

2017